Please wait while the formulary information is being retrieved.
ILARIS (PF) (canakinumab/PF)
- familial cold autoinflammatory syndrome
- Muckle-Wells syndrome
- systemic-onset juvenile idiopathic arthritis
- adult-onset Still's disease
- familial Mediterranean fever
- hyper-IgD periodic fever syndrome
- TNF receptor-associated periodic fever syndrome
- None
Contraindicated
- None
Severe
Moderate
- None
- None
Contraindicated
- None
Severe
Moderate
- None
ILARIS (PF) (canakinumab/PF)
- familial cold autoinflammatory syndrome
- Muckle-Wells syndrome
- systemic-onset juvenile idiopathic arthritis
- adult-onset Still's disease
- familial Mediterranean fever
- hyper-IgD periodic fever syndrome
- TNF receptor-associated periodic fever syndrome
- None
- None
More Frequent
Severe
Less Severe
- None
- None
Less Frequent
Severe
Less Severe
Rare / Very Rare
Severe
- None
Less Severe
- None
Contraindicated
None
Severe Precaution
None
Management or Monitoring Precaution
None
Contraindicated
None
| General | Excretion Potential | Effect on Infant | Notes |
| None |
Precaution Exists
None
| General | Excretion Potential | Effect on Infant | Notes |
| None |
No Known Risk
None
| General | Excretion Potential | Effect on Infant | Notes |
| None |
Contraindicated
None
Precaution Exists
None
No Known Risk
None
- None
Formulary Reference Tool